These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 16418789

  • 1. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS, Cameron ID, Cumming RG, Lord SR, March LM, Sambrook PN, Simpson JM, Seibel MJ.
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [Abstract] [Full Text] [Related]

  • 2. High bone turnover is an independent predictor of mortality in the frail elderly.
    Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seibel MJ.
    J Bone Miner Res; 2006 Apr; 21(4):549-55. PubMed ID: 16598375
    [Abstract] [Full Text] [Related]

  • 3. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 4. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 6. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 Mar; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 7. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B.
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [Abstract] [Full Text] [Related]

  • 8. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 9. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD.
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [Abstract] [Full Text] [Related]

  • 10. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
    Kobayashi T, Gabazza EC, Taguchi O, Risteli J, Risteli L, Kobayashi H, Yasui H, Yuda H, Sakai T, Kaneda M, Adachi Y.
    Cancer; 1999 May 01; 85(9):1951-7. PubMed ID: 10223235
    [Abstract] [Full Text] [Related]

  • 11. Serum markers of bone metabolism in dogs.
    Allen MJ, Hoffmann WE, Richardson DC, Breur GJ.
    Am J Vet Res; 1998 Mar 01; 59(3):250-4. PubMed ID: 9522938
    [Abstract] [Full Text] [Related]

  • 12. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct 01; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R, Thölix E.
    Anticancer Res; 1996 Oct 01; 16(4B):2289-93. PubMed ID: 8694558
    [Abstract] [Full Text] [Related]

  • 14. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J.
    Bone; 2004 Feb 01; 34(2):344-51. PubMed ID: 14962813
    [Abstract] [Full Text] [Related]

  • 15. Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.
    Kowalska M, Druzd-Sitek A, Fuksiewicz M, Kotowicz B, Chechlinska M, Syczewska M, Walewski J, Kaminska J.
    Clin Biochem; 2010 Apr 01; 43(6):604-8. PubMed ID: 20045402
    [Abstract] [Full Text] [Related]

  • 16. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 17. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R, HORIZON-PFT Research Group.
    J Bone Miner Res; 2009 Sep 15; 24(9):1544-51. PubMed ID: 19338427
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men.
    Chandani AK, Scariano JK, Glew RH, Clemens JD, Garry PJ, Baumgartner RN.
    Bone; 2000 May 15; 26(5):513-8. PubMed ID: 10773592
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar 15; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 20. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH.
    J Bone Miner Res; 2005 Nov 15; 20(11):1905-11. PubMed ID: 16234962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.